4//SEC Filing
Garipalli Vivek 4
Accession 0000895345-23-000261
CIK 0001801170other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 8:23 PM ET
Size
29.1 KB
Accession
0000895345-23-000261
Insider Transaction Report
Form 4
Garipalli Vivek
Director10% Owner
Transactions
- Exercise/Conversion
Class A Common Stock
2023-01-07+1,569,594→ 1,569,594 total - Tax Payment
Class A Common Stock
2023-01-07$1.01/sh−1,569,594$1,585,290→ 0 total - Exercise/Conversion
Class B Common Stock
2023-01-07+3,342,698→ 5,020,571 total→ Class A Common Stock (3,342,698 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-01-07−3,342,698→ 10,028,095 total→ Class B Common Stock (3,342,698 underlying) - Exercise/Conversion
Class B Common Stock
2023-01-07−1,569,594→ 3,450,977 total→ Class A Common Stock (1,569,594 underlying)
Holdings
- 75,694,143(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (75,694,143 underlying) - 5,645,934(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (5,645,934 underlying) - 182,201(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (182,201 underlying) - 2,062,265(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (2,062,265 underlying)
Footnotes (4)
- [F1]The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.
- [F2]On January 7, 2023, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,773,104 shares of the Issuer's Class B Common stock being delivered to the Reporting Person and 1,569,594 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.
- [F4]The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001839260
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 8:23 PM ET
- Size
- 29.1 KB